CONTTRIBUTE Trademark

Trademark Overview

On Wednesday, April 15, 2020, a trademark application was filed for CONTTRIBUTE with the United States Patent and Trademark Office. The USPTO has given the CONTTRIBUTE trademark a serial number of 88872680. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by Alnylam Pharmaceuticals, Inc.. The CONTTRIBUTE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Maintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time
conttribute

General Information

Serial Number88872680
Word MarkCONTTRIBUTE
Filing DateWednesday, April 15, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements

Pseudo MarkCONTRIBUTE
Goods and ServicesMaintaining a clinical registry database for patients with mutations of the transthyretin gene; maintaining a registry on the clinical outcomes of ATTR amyloidosis in patients over time

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, April 23, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlnylam Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAlnylam Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, February 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 11, 2022SOU EXTENSION 4 GRANTED
Thursday, August 11, 2022SOU EXTENSION 4 FILED
Thursday, August 11, 2022TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 11, 2022SOU EXTENSION 3 GRANTED
Friday, February 11, 2022SOU EXTENSION 3 FILED
Friday, February 11, 2022TEAS EXTENSION RECEIVED
Wednesday, August 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 9, 2021SOU EXTENSION 2 GRANTED
Monday, August 9, 2021SOU EXTENSION 2 FILED
Monday, August 9, 2021TEAS EXTENSION RECEIVED
Friday, February 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 3, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 3, 2021SOU EXTENSION 1 FILED
Wednesday, February 3, 2021TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2020ASSIGNED TO EXAMINER
Thursday, April 23, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 18, 2020NEW APPLICATION ENTERED

Related Keywords

conttribute patients maintaining registry clinical amyloidosis time attr over transthyretin database